Neurodegeneration in multiple sclerosis

Publisher： Govi-Verlag

ISSN： 2195-2175

Source： PHARMAKON, Vol.2, Iss.6, 2014-11, pp. : 388-394

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neurodegeneration and Neuroprotection in Multiple Sclerosis

By  

Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-10 ,pp. : 4471-4474

Bentham Science Publishers

Access to resources Recommend Favorite

Optical Coherence Tomography Detection of Neurodegeneration in Multiple Sclerosis

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 5, 2012-08 ,pp. : 518-527

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Strategies To Prevent Neurodegeneration And Promote Regeneration In Multiple Sclerosis

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 5, Iss. 1, 2005-01 ,pp. : 11-26

Bentham Science Publishers

Access to resources Recommend Favorite

Commentary: (Research Highlights Inflammation, Demyelination and Neurodegeneration: Risky Buddies in Multiple Sclerosis)

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 1, 2014-02 ,pp. : 4-5

Bentham Science Publishers

Access to resources Recommend Favorite

Activation of Calpain and Caspase Pathways in Demyelination and Neurodegeneration in Animal Model of Multiple Sclerosis

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 3, 2008-06 ,pp. : 313-320

Bentham Science Publishers

Access to resources Recommend Favorite